AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.
Ultima Genomics, founded in 2016 and based in Newark, California, specializes in genome-scale sequencing technology aimed at providing analytical services to enterprises. The company employs an innovative approach using an open substrate that creates a large, low-cost reaction surface, allowing for billions of reads without the need for expensive flow cells or complex fluidics. By integrating specialized sequencing hardware with machine learning, Ultima Genomics ensures reproducible and accurate results, enabling clients to obtain genomic reports rapidly and efficiently. This technology not only enhances the scale of genomic information but also significantly reduces the costs associated with sequencing, thereby facilitating advancements in biology and improvements in human health.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
Cor is a consumer product, with the intention of making it easy to access vital and valuable nutrition and fitness information through your blood. Cor transforms data through machine learning algorithms into “insights.” These insights are information for you based on your lifestyle changes. They include diet, supplements, exercise, and relaxation insights and recommendations. When something you try works for you, you will see an improvement in your indicators. That’s self-efficacy, and that’s just the beginning. You can take these insights and make them into habits. That’s adherence. Over time this becomes permanent improvement. Furthermore, you can share your successes with your family, or anyone you choose. You can help your community by sharing your secrets to success. Cor enables you to see inside your body, quickly and from the comfort of your own home. By providing personalized health insights and key indicator tracking, Cor empowers you to live a longer and healthier life.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.
Robin Healthcare, Inc. is a technology company specializing in healthcare software aimed at alleviating administrative burdens for medical professionals. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company offers a range of solutions including a smart assistant device, clinical documentation tools, order and medication entry, chart reviews, billing and coding, and referral management services. Its innovative electronic medical recording technology utilizes machine learning, artificial intelligence, and voice recognition to seamlessly capture patient notes and facilitate care coordination through natural dialogue between doctors and patients. This approach not only enhances compliance and billing accuracy but also allows healthcare providers to concentrate more on patient care rather than administrative tasks.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
Deep Genomics Inc. is an artificial intelligence therapeutics company that focuses on developing individualized genetic medicines. Founded in 2014 and based in Toronto, Canada, the company utilizes advanced AI systems to enhance various stages of drug discovery and development, including target identification, lead optimization, toxicity evaluation, and trial design. Deep Genomics specializes in creating oligonucleotide therapies that address the genetic causes of diseases at the RNA and DNA levels. Its innovative AI-powered platform analyzes RNA biology to uncover new therapeutic targets and mechanisms that traditional methods cannot access, enabling the development of treatments for rare metabolic, ophthalmologic, and neurodegenerative disorders. The company recruits top talent in genomics, drug development, and AI to drive its mission of revolutionizing drug discovery.
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.
Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.
HealthifyMe is an application that allows its users to achieve their fitness and weight loss goals from their computers and smartphones. The application enables its users to track their calories, nutrition, and fitness activities; track their weight and determine if they are healthy; set healthy goals and work toward meeting them; share their data with experts; and get expert advice and suggestions on their lifestyles. HealthifyMe was developed and launched by a team of doctors, nutritionists, and fitness trainers in 2012. It is based in Bangalore, India.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one.
They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body.
Ochre Bio is within the heart of Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Operator of a wellness brand intended to provide healthcare and personal products for hair loss and weight management issues. The company's platform offers hair care kits, grooming kits, performance products, and weight loss products, enabling men to regain their lost self-confidence.
Hello Heart Inc. is a health technology company that offers a comprehensive application designed to help individuals manage their blood pressure effectively. Founded in 2013 and based in Redwood City, California, the company provides users with a wireless blood pressure monitor paired with a smartphone application that delivers real-time, personalized health tips. The application is particularly aimed at individuals with high blood pressure, empowering them to understand and improve their heart health. By facilitating self-management and promoting behavior change, Hello Heart seeks to prevent serious health risks associated with hypertension, which is a major cost factor for employers. The program is clinically based, ensuring that users receive reliable guidance in an engaging manner.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.
Apton Biosystems, Inc., founded in 2012 and based in Pleasanton, California, operates within the biotechnology sector, focusing on innovative solutions for genetic analysis. The company has developed a high-throughput and low-cost sequencing platform that enhances the availability of genetic testing, facilitating biomarker discovery, early disease detection, and therapeutic monitoring. Apton Biosystems reimagines optical systems for sequencing and single-molecule protein detection, utilizing super-resolution technology to evaluate closely spaced molecules. This approach enables the healthcare sector to create well-defined nanostructures, addressing spatial challenges and advancing high-density sequencing and protein detection capabilities. Through these advancements, Apton Biosystems contributes to the fields of preventive health and precision medicine.
Pendulum Therapeutics Inc., a microbiome company, produces microbiome-targeted medical probiotics. It offers Pendulum Glucose Control, a medical probiotic for the dietary management of type 2 diabetes. The company also develops prebiotics to help feed the probiotic strains. It sells its products online. Pendulum Therapeutics Inc. was formerly known as Whole Biome Inc. and changed its name to Pendulum Therapeutics Inc. in July 2019. The company was incorporated in 2012 and is based in San Francisco, California.
Rightway Healthcare, Inc. operates a healthcare advocacy platform that focuses on optimizing healthcare expenditure for employers and employees. Founded in 2017 and based in New York, the company provides a consumer portal that offers diagnosis education, treatment path navigation, and patient advocacy services. Its platform combines patient navigation with analytics to guide users toward optimal care and therapies, while also simplifying access through an employee application that allows for on-demand navigation. Additionally, Rightway integrates pharmacy benefit management (PBM) solutions into its services, ensuring prescriptions are directed to the lowest net cost. This approach aligns incentives and involves clinicians in the care journey, ultimately aiming to reduce costs and improve health outcomes for its users.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Developer of immunity-boosting proteins designed to improve the lives of people who suffer from food allergies and gluten-related disorders. The company's technology uses artificial intelligence, immunology, computational biology, and protein engineering to make safe proteins that do not trigger an immune response, enabling physicians to prescribe to people products that are safe to consume.
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.
Earli is focused on transforming cancer detection and treatment by developing innovative technologies that enable early identification of tumors. The company specializes in creating synthetic biopsies, which are designed to induce cancer cells to produce non-human synthetic biomarkers. These biomarkers can be detected in biological samples such as blood, urine, or breath, allowing for the visualization of tumors that are typically too small to identify in traditional screenings. By leveraging these programmable genetic constructs, Earli aims to provide real-time data on cancer presence and progression, facilitating personalized treatment approaches and improving the chances of successful intervention. Overall, Earli's mission is to make the experience of cancer more manageable by ensuring timely detection and response.
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
At Invoy, we are committed to leveraging science, data and artificial intelligence to help you reach your health and weight loss goals. Every person has a unique body chemistry and respective set of goals. Invoy strives to be at the forefront of solutions that target your individuality to enhance your performance.
SiPhox Inc. is a company based in Cambridge, Massachusetts, specializing in the design and manufacture of disposable testing kits for COVID-19 and other diseases. Founded in 2020, SiPhox offers a handheld testing device that utilizes advanced technology to perform RNA, DNA, and protein testing. The company's testing kits incorporate multiplexing of RNA, antibody, and antigen tests on a single silicon photonic chip, enhanced by plasmon resonance and silicon photonic resonator readout. This innovative approach allows users to safely conduct tests for various diseases in both point-of-care and at-home settings, using disposable SiPhox Biosensor cartridges and the SiPhox PROBE.
Caption Health, Inc. develops artificial intelligence-based software solutions designed to assist healthcare providers in acquiring and interpreting ultrasound exams. The company's flagship product, Caption AI, offers real-time guidance for performing echocardiography, enabling practitioners to capture diagnostic-quality images, automate quality assessments, and interpret ultrasound results effectively. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company focuses on enhancing the capabilities of ultrasound technology through innovative software, ultimately aiming to improve patient outcomes in medical imaging.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Using AI to control the scanner minimizes the need for breath-holds, making MRI exams available for a broader base of patients and conditions.
Genalyte, Inc. is a clinical and diagnostic life science company based in San Diego, California, specializing in rapid diagnostic testing solutions. Founded in 2007, Genalyte has developed an innovative technology platform that utilizes silicon photonic biosensors to quantify biomolecular interactions, such as those between antibodies and proteins. This platform, known as the Maverick, allows for the direct measurement of protein binding and nucleic acid hybridization. Genalyte's technology is employed by healthcare providers, pharmaceutical companies, and academic researchers to monitor autoimmune diseases, screen for cancer biomarkers, detect anti-drug antibodies, and test for infectious agents, including Ebola. The company aims to enhance patient care by enabling rapid diagnostics, with tests typically completed in under thirty minutes, and providing mobile laboratory solutions for real-time diagnostics.
Yes Health Inc. is a California-based company that specializes in mobile health solutions, focusing on diabetes prevention and management. Founded in 2015, it offers a comprehensive application that provides personalized nutrition and fitness advice, as well as support from health coaches. The program is designed to engage users actively, making it accessible and effective for individuals looking to adopt healthier lifestyles and prevent the onset of diabetes. Yes Health's team comprises physicians, health coaches, and engineers who work together to create a program that is both affordable and easy to follow. In addition to prevention, the application also aids individuals already diagnosed with diabetes in managing their symptoms effectively, with the overarching mission of promoting lasting health habits and reducing the impact of diabetes.
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread.
The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
Karius, Inc. is a life sciences company dedicated to generating genomic insights for infectious diseases. It offers the Karius Test, a non-invasive blood test that utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. Karius also provides laboratory services for pathogen biomarker detection tailored for biopharmaceutical companies. Founded in 2014, the company is based in Redwood City, California, with an additional office in Menlo Park. Its laboratory holds CLIA certification and CAP accreditation, allowing it to conduct high-complexity clinical laboratory testing to support rapid clinical decision-making.
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Deep Genomics Inc. is an artificial intelligence therapeutics company that focuses on developing individualized genetic medicines. Founded in 2014 and based in Toronto, Canada, the company utilizes advanced AI systems to enhance various stages of drug discovery and development, including target identification, lead optimization, toxicity evaluation, and trial design. Deep Genomics specializes in creating oligonucleotide therapies that address the genetic causes of diseases at the RNA and DNA levels. Its innovative AI-powered platform analyzes RNA biology to uncover new therapeutic targets and mechanisms that traditional methods cannot access, enabling the development of treatments for rare metabolic, ophthalmologic, and neurodegenerative disorders. The company recruits top talent in genomics, drug development, and AI to drive its mission of revolutionizing drug discovery.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Digi-Prex operates a monthly medication delivery platform that focuses on serving patients with chronic diseases in India. Founded in 2019 and headquartered in Hyderabad, with an additional office in San Francisco, the company enables patients to upload prescriptions and receive their medications at discounted rates from local pharmacies. In addition to medication delivery, Digi-Prex offers a comprehensive management solution tailored to individual health needs, providing a one-stop platform for chronic disease management. This approach aims to simplify access to necessary treatments while supporting patients in effectively managing their health conditions.
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.
Hello Heart Inc. is a health technology company that offers a comprehensive application designed to help individuals manage their blood pressure effectively. Founded in 2013 and based in Redwood City, California, the company provides users with a wireless blood pressure monitor paired with a smartphone application that delivers real-time, personalized health tips. The application is particularly aimed at individuals with high blood pressure, empowering them to understand and improve their heart health. By facilitating self-management and promoting behavior change, Hello Heart seeks to prevent serious health risks associated with hypertension, which is a major cost factor for employers. The program is clinically based, ensuring that users receive reliable guidance in an engaging manner.
Probably Genetic is dedicated to assisting individuals with rare genetic conditions that are often misdiagnosed as autism spectrum disorder. Typically, patients endure an exhausting wait of up to seven years to receive accurate diagnoses, leading to significant emotional and financial burdens as they consult numerous doctors and specialists. To address this issue, Probably Genetic provides educational resources and DNA sequencing tests, facilitating a more straightforward path to understanding whether there may be underlying genetic factors contributing to their symptoms. The organization's goal is to support those who are overlooked by the existing healthcare system, ultimately helping families find clarity and answers more efficiently.
Neurotrack Technologies, Inc., founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, is based in Redwood City, California. The company focuses on transforming the diagnosis and prevention of Alzheimer’s and related dementias through its innovative app-based Cognitive Health Program. Neurotrack offers a computer-based cognitive test that detects impairment in the hippocampus, a key area affected by Alzheimer’s. Utilizing advanced eye-tracking technology, the company provides digital cognitive assessments alongside a personalized intervention program. This approach empowers individuals of all ages to enhance their cognitive health through regular “brain checkups” and targeted lifestyle changes, aiming to improve overall cognitive function and prevent dementia-related conditions.
Pendulum Therapeutics Inc., a microbiome company, produces microbiome-targeted medical probiotics. It offers Pendulum Glucose Control, a medical probiotic for the dietary management of type 2 diabetes. The company also develops prebiotics to help feed the probiotic strains. It sells its products online. Pendulum Therapeutics Inc. was formerly known as Whole Biome Inc. and changed its name to Pendulum Therapeutics Inc. in July 2019. The company was incorporated in 2012 and is based in San Francisco, California.
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.
DocBot, Inc. is a technology company based in Irvine, California, that develops web-based applications for iOS and Android devices. The company's offerings include a clinical decision support system and cloud analytics, which aggregate patient information to assist physicians and specialists in delivering improved care. Additionally, DocBot has created an image analysis platform specifically designed to aid in the detection of colorectal cancer and gastrointestinal diseases. This platform integrates various data sources, including imaging systems and pathology requisitions, enabling healthcare providers to enhance patient outcomes while reducing cancer risk. Through its commitment to intuitive software design, DocBot aims to empower physicians in their clinical decision-making processes.
BioAge Labs, Inc. is a biotechnology company focused on developing therapies for aging and age-related diseases. The company utilizes a proprietary systems biology and artificial intelligence platform to identify crucial drug targets that influence aging, leveraging extensive datasets to uncover the molecular drivers behind age-related conditions. BioAge Labs offers several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor aimed at treating multiple diseases of aging by activating HIF-1 target genes linked to various biological processes such as tissue regeneration and vascular remodeling. Another candidate, BGE-175, is an orally administered inhibitor that targets the prostaglandin D2 DP1 signaling pathway, which is associated with increased mortality risk and susceptibility to infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to advancing the understanding and treatment of aging-related health issues.
Loop Genomics is a platform technology for long-read DNA sequencing. Loop Genomics technology transforms short-read DNA sequencers into high-throughput, long-read, single-molecule DNA sequencing machines. Loop Genomics long-read DNA sequencing technology provides phased sequencing solutions across a diverse repertoire of research and clinical applications. Sequencing of partial rRNA gene sequences results in reduced phylogenetic resolution. Full-length, high-throughput, phased sequencing that covers all 16S variable regions is becoming the gold standard for profiling the microbiome. Achieve the highest resolution microbial community profiling with long-read, next-generation sequencing of the microbiome. Characterizing polymorphisms in HLA genes inside and outside of the protein-coding regions is important for organ transplantation compatibility testing and for strengthening causality association studies. The length of homologous sequences between HLA alleles extends beyond the capabilities of short-read sequencing platforms, resulting in diploid ambiguities and a reliance on imputation. Sequence full-length HLA DNA and/or RNA with phased, high throughput, long-read sequencing that resolves allelic discrimination and diploid ambiguity. Viral genetic variability is a major determinant of viral drug resistance and viral vaccine efficacy. Accurately mapping viral genetic variability is a critical step in choosing the optimal course of therapy and developing efficacious vaccines. Key mutations are typically located throughout long stretches of viral genomes, making the retrieval of critical phased data challenging using short-read sequencing technology. Use phased, high-throughput DNA sequencing technology to map key mutations at the quasi-species level and generate a complete phased map of viral populations.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
Higia Technologies, founded in 2016 and based in Mexico City, has developed EVA, an accessible and non-invasive wearable device aimed at assessing breast cancer risk. The device features tactile sensors that map the surface of the breast and its surrounding areas, enabling women to monitor changes in breast temperature, size, and weight. Equipped with biosensors, EVA continuously collects and analyzes this information, providing users with a reliable tool for tracking their breast health.
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Neurotrack Technologies, Inc., founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, is based in Redwood City, California. The company focuses on transforming the diagnosis and prevention of Alzheimer’s and related dementias through its innovative app-based Cognitive Health Program. Neurotrack offers a computer-based cognitive test that detects impairment in the hippocampus, a key area affected by Alzheimer’s. Utilizing advanced eye-tracking technology, the company provides digital cognitive assessments alongside a personalized intervention program. This approach empowers individuals of all ages to enhance their cognitive health through regular “brain checkups” and targeted lifestyle changes, aiming to improve overall cognitive function and prevent dementia-related conditions.
Clara Health is a medical technology company that offers a software platform designed to facilitate patient participation in clinical trials. The platform simplifies the clinical trial process by assisting patients in navigating through various options, allowing them to filter and connect with relevant trials tailored to their needs. Additionally, Clara's technology supports crucial aspects of clinical trial management, including protocol design, site selection, and monitoring patient adherence. By placing the patient at the center of the process, Clara Health aims to enhance accessibility and engagement in clinical research.
DiscernDx is a healthcare company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to personalized clinical and molecular data, enabling proactive health management. By leveraging artificial intelligence and machine learning, DiscernDx's platform detects, measures, and interprets signals from the body, facilitating early disease detection and personalized care. This approach empowers individuals to make informed health decisions, ultimately aiming to improve lives and transform healthcare practices.
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.
Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.
DocTalk Solutions India Private Limited develops and offers a mobile application that enables patients to communicate with their doctors. The company's application enables users to chat with their doctor, save medical reports, and get prescriptions. DocTalk Solutions India Private Limited was founded in 2016 and is based in Mumbai, India.
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool.
The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more.
Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.
Totemic makes a device to monitor the health and safety of older adults in a completely passive way--with no wearables required. We are solving the problem of how society will take care of 50m+ older adults in the US in a scalable & humane manner. They can monitor the most salient pieces of information in an older adult's day to day: serious health events like falls, behavioral red flags such as changes in urination frequency, skipping meals, or being bedridden which can all correlate with health decline.
Deep Genomics Inc. is an artificial intelligence therapeutics company that focuses on developing individualized genetic medicines. Founded in 2014 and based in Toronto, Canada, the company utilizes advanced AI systems to enhance various stages of drug discovery and development, including target identification, lead optimization, toxicity evaluation, and trial design. Deep Genomics specializes in creating oligonucleotide therapies that address the genetic causes of diseases at the RNA and DNA levels. Its innovative AI-powered platform analyzes RNA biology to uncover new therapeutic targets and mechanisms that traditional methods cannot access, enabling the development of treatments for rare metabolic, ophthalmologic, and neurodegenerative disorders. The company recruits top talent in genomics, drug development, and AI to drive its mission of revolutionizing drug discovery.
Karius, Inc. is a life sciences company dedicated to generating genomic insights for infectious diseases. It offers the Karius Test, a non-invasive blood test that utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. Karius also provides laboratory services for pathogen biomarker detection tailored for biopharmaceutical companies. Founded in 2014, the company is based in Redwood City, California, with an additional office in Menlo Park. Its laboratory holds CLIA certification and CAP accreditation, allowing it to conduct high-complexity clinical laboratory testing to support rapid clinical decision-making.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Developer of immunity-boosting proteins designed to improve the lives of people who suffer from food allergies and gluten-related disorders. The company's technology uses artificial intelligence, immunology, computational biology, and protein engineering to make safe proteins that do not trigger an immune response, enabling physicians to prescribe to people products that are safe to consume.
MDAlgorithms uses smart algorithms, computer vision, and AI to provide real time mobile tools for people with health disorders. The company's mission is to disrupt the old physician centric medical system and put the patient in the center.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool.
The platform enables users to co-create personalized care plans that serve as common ground for collaboration with their care team: their own providers such as physicians and nurse practitioners; their family and friends; and coaches such as nurses, pharmacists, health coaches, and more.
Twine Health was developed at the MIT Medical Lab by John Moore and Frank Moss and its operations are based in Massachusetts, United States.
Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes (proteins, viruses, antibodies, etc) from any life form. Use in human and animal diagnostics, agriculture, food safety testing, environmental monitoring, and more. Our platforms use silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules. We will help transform point-of-care testing and third generation sequencing.
DocTalk Solutions India Private Limited develops and offers a mobile application that enables patients to communicate with their doctors. The company's application enables users to chat with their doctor, save medical reports, and get prescriptions. DocTalk Solutions India Private Limited was founded in 2016 and is based in Mumbai, India.
MDacne mission is to disrupt the old physician-centric medical system and put the patient in the center. Using smart algorithms and computer vision to provide real-time mobile tools for people with health disorders. The company's first mobile app, MDacne, targets 500 million people suffering from Acne and provides them an immediate self-diagnosis personalized treatment plan in order to treat their Acne and enhance their quality of life.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.